IP Library Granted Patent US 8,648,082
Granted Patent B2
US 8,648,082 · App. 10/279,704 · Granted Feb 11, 2014

Gum resin as a carrier for topical application of antimicrobial agents

Inventors: Alex Battaglia (La Jolla, CA); Eva Beim (La Jolla, CA)
Assignee: Jaleva, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,648,082
App. No.
10/279,704
Granted
Feb 11, 2014
Kind
B2
Abstract

The invention provides a biological dressing for treatment of a dermatological disease comprised of a gum resin, a topically acceptable volatile solvent, and a pharmacologically active agent. The gum resin is present in a suitable amount that the composition, when the solvent evaporates, will dry to form a solid coating that sticks to the skin or mucosal membrane to which the composition is applied and maintain the pharmacologically active agent over a sustained period of time in contact with sites on the skin or mucosal membranes exhibiting symptoms of the disease. Methods are provided for treating symptoms of dermatological diseases with such a pharmacological composition. Biological dressings including tincture of benzoin and clotrimazole are shown to be efficacious for the long-term amelioration of symptoms of athlete's foot.

Claims (25)

1. A composition comprising:

a) mastic gum in an amount of about 10% to about 40%;

b) at least one topically acceptable agent selected from the group consisting of clindamycin, erythromycin, tetracycline, mupirocin, gentamicin, metronidizole, bacitracin, neomycin, polymyxin B, and clotrimazole; and

c) a topically acceptable volatile solvent in an amount of about 60% to about 90%, wherein the solvent is selected from the group consisting of isopropanol and ethanol.

2. The composition according to claim 1 , wherein the topically acceptable volatile solvent comprises ethanol.

3. The composition according to claim 1 , wherein the agent is clotrimazole.

4. The composition according to claim 1 , further comprising a penetration enhancer.

5. A composition comprising:

a) mastic gum in an amount of about 10% to about 40%;

b) clotrimazole; and

c) ethanol in an amount of about 60% to about 90%.

6. A composition comprising:

a) mastic gum in an amount of about 10% to about 40%;

b) 1% clotrimazole; and

c) 60% ethanol.

7. The composition according to claim 1 , wherein the agent is bacitracin.

8. A composition comprising: a) mastic gum; b) bacitracin; c) Polymyxin B; and d) 90% ethanol.

9. A composition comprising: a) mastic gum in an amount of about 10%; b) 1% clotrimazole; and c) 90% ethanol.

10. The composition according to claim 4 , wherein the penetration enhancer is dimethylsulfoxide.

11. The composition according to any one of claims 1 , 5 , and 6 , further comprising an oil.

12. A liquid composition consisting essentially of:

a) a mastic gum in an amount of about 10% to about 40%;

b) at least one topically acceptable agent selected from the group consisting of clindamycin, erythromycin, tetracycline, mupirocin, gentamicin, metronidizole, bacitracin, neomycin, polymyxin B, and clotrimazole; and

c) a topically acceptable volatile solvent for the mastic gum and the agent in an amount of about 60% to about 90%, wherein the solvent is selected from the group consisting of isopropanol and ethanol.

13. The composition according to claim 12 , wherein the agent is bacitracin.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2022
From: BATTAGLIA, ALEX
To: TRIFECTA THERAPEUTICS LLC
Reel/Frame 061860/0065 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 046087 FRAME: 0363. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 21, 2018
From: JALEVA PHARMACEUTICALS, LLC
To: ADVANCED RESIN THERAPEUTICS, INC.
Reel/Frame 046407/0441 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2018
From: JAVELA PHARMACEUTICALS, LLC
To: ADVANCED RESIN THERAPEUTICS, INC.
Reel/Frame 046087/0363 →
CHANGE OF NAME Recorded Mar 31, 2014
From: JALEVA, LLC
To: JALEVA PHARMACEUTICALS, LLC
Reel/Frame 032568/0870 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2008
From: JALEVA, INC.
To: JALEVA, LLC
Reel/Frame 021018/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2004
From: BATTAGLIA, ALEX; BEIM, EVA
To: JALEVA, INC.
Reel/Frame 015172/0239 →
Continuity (3)
Continuation In Part 10053313 · Jan 18, 2002
Provisional Application 60299377 · Jun 18, 2001
Related Publication 20030068331A1 · Apr 10, 2003